These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8115787)
1. Mortality rates by stage-at-diagnosis. Clinton K Semin Surg Oncol; 1994; 10(1):7-11. PubMed ID: 8115787 [TBL] [Abstract][Full Text] [Related]
2. On the estimation of survival. Henson DE; Ries LA Semin Surg Oncol; 1994; 10(1):2-6. PubMed ID: 8115782 [TBL] [Abstract][Full Text] [Related]
3. Stage at diagnosis and early mortality from cancer in England. McPhail S; Johnson S; Greenberg D; Peake M; Rous B Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389 [TBL] [Abstract][Full Text] [Related]
4. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764 [TBL] [Abstract][Full Text] [Related]
5. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691 [TBL] [Abstract][Full Text] [Related]
6. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171 [TBL] [Abstract][Full Text] [Related]
7. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival. Hu CY; Xing Y; Cormier JN; Chang GJ Cancer; 2013 May; 119(10):1900-7. PubMed ID: 23408226 [TBL] [Abstract][Full Text] [Related]
8. Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership. Walters S; Maringe C; Butler J; Brierley JD; Rachet B; Coleman MP Int J Cancer; 2013 Feb; 132(3):676-85. PubMed ID: 22623157 [TBL] [Abstract][Full Text] [Related]
9. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer. Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835 [TBL] [Abstract][Full Text] [Related]
10. Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence. Cho H; Mariotto AB; Mann BS; Klabunde CN; Feuer EJ Am J Epidemiol; 2013 Aug; 178(3):339-49. PubMed ID: 23825168 [TBL] [Abstract][Full Text] [Related]
11. Influence of extent of disease, histology, and demographic factors on lung cancer survival in the SEER population-based data. Ries LA Semin Surg Oncol; 1994; 10(1):21-30. PubMed ID: 8115783 [TBL] [Abstract][Full Text] [Related]
12. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Kosary CL Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784 [TBL] [Abstract][Full Text] [Related]
13. Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia. Lawrance S; Bui C; Mahindra V; Arcorace M; Cooke-Yarborough C BMC Cancer; 2019 Aug; 19(1):850. PubMed ID: 31462255 [TBL] [Abstract][Full Text] [Related]
14. The impact of state-specific life tables on relative survival. Stroup AM; Cho H; Scoppa SM; Weir HK; Mariotto AB J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):218-27. PubMed ID: 25417235 [TBL] [Abstract][Full Text] [Related]
15. Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India. Yeole BB; Kumar AV Asian Pac J Cancer Prev; 2004; 5(2):175-82. PubMed ID: 15244521 [TBL] [Abstract][Full Text] [Related]
16. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748 [TBL] [Abstract][Full Text] [Related]
17. Evaluating factors associated with unknown SEER Summary Stage 2000 derived from collaborative stage at central registry level. Hsieh MC; Yu Q; Wu XC; Wohler B; Fan Y; Qiao B; Jemal A; Ajani UA J Registry Manag; 2012; 39(3):101-6. PubMed ID: 23443453 [TBL] [Abstract][Full Text] [Related]
18. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
19. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Hassett MJ; Ritzwoller DP; Taback N; Carroll N; Cronin AM; Ting GV; Schrag D; Warren JL; Hornbrook MC; Weeks JC Med Care; 2014 Oct; 52(10):e65-73. PubMed ID: 23222531 [TBL] [Abstract][Full Text] [Related]
20. Cancer mortality surveillance--United States, 1990-2000. Stewart SL; King JB; Thompson TD; Friedman C; Wingo PA MMWR Surveill Summ; 2004 Jun; 53(3):1-108. PubMed ID: 15179359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]